Baird Initiates Coverage On Immutep with Outperform Rating, Announces Price Target of $7
Portfolio Pulse from richadhand@benzinga.com
Baird analyst Joel Beatty has initiated coverage on Immutep (NASDAQ:IMMP) with an Outperform rating and a price target of $7.
August 04, 2023 | 12:41 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immutep has received an Outperform rating from Baird with a price target of $7.
The Outperform rating from Baird indicates a positive outlook for Immutep. The price target of $7 suggests a potential upside, which could attract investors and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100